- Home
- FEBO vs NXPL Comparison
FEBO vs NXPL Comparison
Compare FEBO & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- NXPL
- Stock Information
- Founded
- FEBO 1993
- NXPL 1997
- Country
- FEBO Hong Kong
- NXPL United States
- Employees
- FEBO N/A
- NXPL N/A
- Industry
- FEBO
- NXPL Telecommunications Equipment
- Sector
- FEBO
- NXPL Telecommunications
- Exchange
- FEBO Nasdaq
- NXPL Nasdaq
- Market Cap
- FEBO 12.7M
- NXPL 13.8M
- IPO Year
- FEBO 2023
- NXPL N/A
- Fundamental
- Price
- FEBO $1.12
- NXPL $0.67
- Analyst Decision
- FEBO
- NXPL
- Analyst Count
- FEBO 0
- NXPL 0
- Target Price
- FEBO N/A
- NXPL N/A
- AVG Volume (30 Days)
- FEBO 7.7K
- NXPL 52.4K
- Earning Date
- FEBO 06-17-2025
- NXPL 05-15-2025
- Dividend Yield
- FEBO N/A
- NXPL N/A
- EPS Growth
- FEBO N/A
- NXPL N/A
- EPS
- FEBO N/A
- NXPL N/A
- Revenue
- FEBO $17,110,653.00
- NXPL $62,515,000.00
- Revenue This Year
- FEBO N/A
- NXPL N/A
- Revenue Next Year
- FEBO N/A
- NXPL N/A
- P/E Ratio
- FEBO N/A
- NXPL N/A
- Revenue Growth
- FEBO 11.58
- NXPL 19.36
- 52 Week Low
- FEBO $0.93
- NXPL $0.43
- 52 Week High
- FEBO $17.68
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- FEBO 43.81
- NXPL 60.79
- Support Level
- FEBO $1.11
- NXPL $0.60
- Resistance Level
- FEBO $1.40
- NXPL $0.71
- Average True Range (ATR)
- FEBO 0.12
- NXPL 0.05
- MACD
- FEBO -0.03
- NXPL 0.01
- Stochastic Oscillator
- FEBO 21.33
- NXPL 93.33
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care c principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.